Cookie Policy         The Babraham Research Campus is also home to The Babraham Institute

  Babraham Bioscience Technologies
        Babraham Research Campus - Cambridge - UK


Video Library


Press Releases and Media Reports 2011



7th November 2011
Antitope, Ltd., Announces Antibody Research Agreement with Therapure Biopharma, Inc.


18th October 2011
Population Genetics raises $5.7M in a Series B financing and announces research agreement with Syngenta Biotechnology


20th September 2011
Spotlight on area's science potential
Cambridge News (Business)


6th September 2011
Growth Factor Technology to Accelerate the Dawn of Stem Cell Therapies


25th August 2011
MISSION Therapeutics, a new Cambridge-based spin-out company, secures £6M in Series-A funding led by Sofinnova Partners


9th August 2011
Cell Guidance Systems awarded £100k for the development of next generation growth factors


1st August 2011
Babraham Bioscience Technologies (BBT) becomes a One Nucleus Partner


27th July 2011
Antitope Ltd. Announces Research Cooperation with the University of North Carolina at Chapel Hill


20th July 2011 Business Weekly
Babraham hosts inaugural BioAcademic Showcase


22nd June 2011
Crescendo Biologics Appoints Matthew Roe as Chief Business Officer


16nd June 2011
Cell Guidance Systems Ltd today announces the launch of Pluripro® p300 media and Pluripro® MATRIX - a new way of maintaining and expanding culture of human pluripotent cells


14th June 2011
Antitope Ltd. Announces Humanization Research Agreement with IMMIH, University of Cologne


9th June 2011
Life at the core of the Cambridge cluster


7th June 2011
Antitope Ltd. Announces Humanization Research Agreement with NasVax Ltd.


6th June 2011
Babraham's Biotechnology Investment Forum 2011 fosters finance opportunities for 16 companies


27th May 2011
New addition to Babraham campus


May 2011
One Nucleus Newsletter


24th March 2011
Babraham Research Campus receives £44M boost for bioscience innovation


8th March 2011
Dennis Camilleri, Rapid Biosensor and Johnson & Johnson sign deal for TB Diagnostics


23rd February 2011
StemCells, Inc. to Present at New York Stem Cell Summit


22nd February 2011
Alpha Biologics and Viropro


17th February 2011
StemCells, Inc. Completes Dosing in Second Trial of HuCNS-SC(R) Neural Stem Cells


11th February 2011
Senexis featured in Business Weekly article


8th February 2011
StemCells, Inc. to Present at BIO CEO & Investor Conference


3rd February 2011
Eagle and Manchester sign KTA for Taverna


February 2011
Rapid Biosensor Systems announces a strategic agreement and collaboration on TB Diagnostics


24th January 2011
Eagle Genomics at Bench-to-Boardroom – March 8th2011


19th January 2011
StemCells, Inc. Broadens Its SC Proven(R) Product Portfolio With Launch of Two Additional Human Cell Detection Antibodies


17th January 2011
Eagle Genomics Symposium – April 5th 2011


14th January 2011
Building on a legacy in antibody research - report on BBSRC website


6th January 2011
Bicycle Therapeutics appoints Andy Sandham as non-executive Chairman


5th January 2011
Mike Romanos Appointed as CEO of Crescendo Biologics


4th January 2011
Eagle becomes an Amazon Solution Provider




Babraham Bioscience Technologies Ltd - Cambridge - United Kingdom